Effect of Erythromycin on the absorption, metabolism and elimination of CHF6001 in healthy volunteers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507300-30-00

Acronym

CLI-06001AA1-14

Enrollment

Registered

2024-02-12

Start date

2024-03-27

Completion date

2024-06-18

Last updated

2024-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study is a phase I trial to investigate the effect of inhibition of CYP3A4/5 by Erythromycin on the pharmacokinetics of CHF6001 in healthy volunteers.

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Countries

Bulgaria

Outcome results